BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi HY, Levy AN, Trivedi HD, Chan FKL, Ng SC, Ananthakrishnan AN. Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies. Clin Gastroenterol Hepatol 2018;16:190-197.e11. [PMID: 28603049 DOI: 10.1016/j.cgh.2017.05.047] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 10.2] [Reference Citation Analysis]
Number Citing Articles
1 Pérez-Jeldres T, Pizarro B, Ascui G, Orellana M, Cerda-Villablanca M, Alvares D, de la Vega A, Cannistra M, Cornejo B, Baéz P, Silva V, Arriagada E, Rivera-Nieves J, Estela R, Hernández-Rocha C, Álvarez-Lobos M, Tobar F. Ethnicity influences phenotype and clinical outcomes: Comparing a South American with a North American inflammatory bowel disease cohort. Medicine (Baltimore) 2022;101:e30216. [PMID: 36086782 DOI: 10.1097/MD.0000000000030216] [Reference Citation Analysis]
2 Greywoode R, Petralia F, Ullman TA, Frederic Colombel J, Ungaro RC. Racial Difference in Efficacy of Golimumab in Ulcerative Colitis. Inflamm Bowel Dis 2022:izac161. [PMID: 35913121 DOI: 10.1093/ibd/izac161] [Reference Citation Analysis]
3 Odufalu FD, Aboubakr A, Anyane-Yeboa A. Inflammatory bowel disease in underserved populations: lessons for practice. Curr Opin Gastroenterol 2022;38:321-7. [PMID: 35762691 DOI: 10.1097/MOG.0000000000000855] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cho S, Stroup BM, Britto SL, Ruan W, Schady D, Hoffman KL, Kellermayer R. Increased number of children in households may protect against inflammatory bowel disease. Pediatr Res 2022. [PMID: 35701607 DOI: 10.1038/s41390-022-02149-x] [Reference Citation Analysis]
5 Rabie EA, Sayed ISM, Amr K, Ahmed HA, Mostafa MI, Hassib NF, El-Sayed H, Zada SK, El-Kamah G. Confirmation of a Phenotypic Entity for TSPEAR Variants in Egyptian Ectodermal Dysplasia Patients and Role of Ethnicity. Genes (Basel) 2022;13:1056. [PMID: 35741818 DOI: 10.3390/genes13061056] [Reference Citation Analysis]
6 Goh XT, Fong SK, Chai HC, Kee BP, Chua KH. The first association study of Protein Tyrosine Phosphatase, Non-Receptor Type 2 (PTPN2) gene polymorphisms in Malaysian patients with Crohn's disease. Gene 2022;836:146661. [PMID: 35680018 DOI: 10.1016/j.gene.2022.146661] [Reference Citation Analysis]
7 Damas OM, Kuftinec G, Khakoo NS, Morillo D, Quintero MA, Levitt J, Lopez J, Kerman DH, Abreu MT, Deshpande AR, Schwartz SJ, Palacio A. Social barriers influence inflammatory bowel disease (IBD) outcomes and disproportionally affect Hispanics and non-Hispanic Blacks with IBD. Therap Adv Gastroenterol 2022;15:175628482210791. [DOI: 10.1177/17562848221079162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Avalos DJ, Satiya J, Contreras A, Trivedi S, Alvarado L, Dodoo C, Dwivedi AK, Zuckerman MJ. Latin Americans and US Hispanics show differences in IBD phenotype: a systematic review with meta-analysis. J Investig Med 2021:jim-2021-001846. [PMID: 34933995 DOI: 10.1136/jim-2021-001846] [Reference Citation Analysis]
9 Asowata OE, Singh A, Ngoepe A, Herbert N, Fardoos R, Reddy K, Zungu Y, Nene F, Mthabela N, Ramjit D, Karim F, Govender K, Ndung'u T, Porterfield JZ, Adamson JH, Madela FG, Manzini VT, Anderson F, Leslie A, Kløverpris HN. Irreversible depletion of intestinal CD4+ T cells is associated with T cell activation during chronic HIV infection. JCI Insight 2021;6:e146162. [PMID: 34618690 DOI: 10.1172/jci.insight.146162] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Um SH, Lee SW, Song KH, Lee SM, Choe BH, Lee YM, Kang B. Incidentally Detected Asymptomatic Perianal Abscess in an Adolescent during Crohn's Disease Diagnosis: Is Routine Pelvic Imaging Required in Korean Pediatric Patients at Diagnosis? Pediatr Gastroenterol Hepatol Nutr 2021;24:564-70. [PMID: 34796101 DOI: 10.5223/pghn.2021.24.6.564] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Najafimehr H, Aghdaei HA, Pourhoseingholi MA, Shalmani HM, Vahedian-Azimi A, Kroh M, Zali MR, Sahebkar A. A Systematic Review and Meta-Analysis on the Association between Inflammatory Bowel Disease Family History and Colorectal Cancer. Gastroenterol Res Pract 2021;2021:4874459. [PMID: 34725546 DOI: 10.1155/2021/4874459] [Reference Citation Analysis]
12 Booth A, Ford W, Brennan E, Magwood G, Forster E, Curran T. Towards Equitable Surgical Management of Inflammatory Bowel Disease: A Systematic Review of Disparities in Surgery for Inflammatory Bowel Disease. Inflamm Bowel Dis 2021:izab237. [PMID: 34553754 DOI: 10.1093/ibd/izab237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Chin YH, Ng CH, Lin SY, Jain SR, Kong G, Koh JWH, Tan DJH, Ong DEH, Muthiah MD, Chong CS, Foo FJ, Leong R, Chan WPW. Systematic review with meta-analysis: The prevalence, risk factors and outcomes of upper gastrointestinal tract Crohn's disease. Dig Liver Dis 2021;53:1548-58. [PMID: 34412995 DOI: 10.1016/j.dld.2021.07.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Dhaliwal J, Carroll MW, deBruyn JC, Ricciuto A, Benchimol EI, Lawrence S, Sherlock M, El-Matary W, Brill H, Church P, Wine E, Carman N, Muise A, Huynh H, Mack D, Walters TD, Griffiths AM, Jacobson K. The phenotypic spectrum of new onset IBD in Canadian children of South Asian ethnicity: A prospective multi-centre comparative study. J Crohns Colitis 2021:jjab143. [PMID: 34379117 DOI: 10.1093/ecco-jcc/jjab143] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Mousavi T, Nikfar S, Abdollahi M. Comprehensive study on the administrative, economic, regional, and regulatory prospects of complementary and alternative medicine (CAM) in inflammatory bowel disease (IBD). Expert Rev Clin Pharmacol 2021;14:865-88. [PMID: 33993811 DOI: 10.1080/17512433.2021.1925108] [Reference Citation Analysis]
16 Turner J, Higgins R, Childs E. Microaggression and Implicit Bias. Am Surg 2021;:31348211023418. [PMID: 34078131 DOI: 10.1177/00031348211023418] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Peña-Sánchez JN, Osei JA, Marques Santos JD, Jennings D, Andkhoie M, Brass C, Bukassa-Kazadi G, Lu X, Johnson-Jennings M, Porter L, Porter R, Quintin CL, Sanderson R, Teucher U, Fowler S. Increasing Prevalence and Stable Incidence Rates of Inflammatory Bowel Disease Among First Nations: Population-Based Evidence From a Western Canadian Province. Inflamm Bowel Dis 2021:izab096. [PMID: 34037223 DOI: 10.1093/ibd/izab096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Liu JJ. Disparity in the Care of black Inflammatory Bowel Disease Patients. Inflamm Bowel Dis 2021:izab100. [PMID: 34037231 DOI: 10.1093/ibd/izab100] [Reference Citation Analysis]
19 Mak JWY, Ng SC. Epidemiology of fibrostenosing inflammatory bowel disease. J Dig Dis 2020;21:332-5. [PMID: 32105396 DOI: 10.1111/1751-2980.12853] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
20 Khan N, Patel D, Pernes T, Patel M, Trivedi C, Medvedeva E, Xie D, Yang Y. The Efficacy and Safety of Switching From Originator Infliximab to Single or Double Switch Biosimilar Among a Nationwide Cohort of Inflammatory Bowel Disease Patients. Crohn's & Colitis 360 2021;3:otab022. [DOI: 10.1093/crocol/otab022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Yen HH, Hsu TC, Chen MW, Su PY, Chen YY. Clinical features and treatment of inflammatory bowel disease in a low-incidence area: A hospital-based retrospective cohort study in Taiwan. Medicine (Baltimore) 2021;100:e25090. [PMID: 33725901 DOI: 10.1097/MD.0000000000025090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
22 Mak JWY, Lok Tung Ho C, Wong K, Cheng TY, Yip TCF, Leung WK, Li M, Lo FH, Ng KM, Sze SF, Leung CM, Tsang SWC, Shan EHS, Chan KH, Lam BCY, Hui AJ, Chow WH, Ng SC. Epidemiology and Natural History of Elderly-onset Inflammatory Bowel Disease: Results From a Territory-wide Hong Kong IBD Registry. J Crohns Colitis 2021;15:401-8. [PMID: 32914171 DOI: 10.1093/ecco-jcc/jjaa181] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
23 Gearry RB, McCombie AM, Vatn M, Rubin DT, Steinwurz F, Loftus EV, Kruis W, Tysk C, Colombel JF, Ng SC, Van Assche G, Bernstein CN. What Are the Most Challenging Aspects of Inflammatory Bowel Disease? An International Survey of Gastroenterologists Comparing Developed and Developing Countries. Inflamm Intest Dis 2021;6:78-86. [PMID: 34124179 DOI: 10.1159/000512310] [Reference Citation Analysis]
24 Kim ES, Kwon Y, Choe YH, Kim MJ. Upper gastrointestinal tract involvement is more prevalent in Korean patients with pediatric Crohn's disease than in European patients. Sci Rep 2020;10:19032. [PMID: 33149222 DOI: 10.1038/s41598-020-75938-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
25 Barnes EL, Loftus EV Jr, Kappelman MD. Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases. Gastroenterology 2021;160:677-89. [PMID: 33098884 DOI: 10.1053/j.gastro.2020.08.064] [Cited by in Crossref: 9] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
26 Oh SJ, Shin GY, Soh H, Lee JG, Im JP, Eun CS, Lee KM, Park DI, Han DS, Kim HJ, Lee CK. Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis. Intest Res 2021;19:323-31. [PMID: 32806875 DOI: 10.5217/ir.2020.00039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Cha JM, Park SH, Rhee KH, Hong SN, Kim YH, Seo SI, Kim KH, Jeong SK, Lee JH, Park SY, Park H, Kim JS, Im JP, Yoon H, Kim SH, Jang J, Kim JH, Suh SO, Kim YK, Ye BD, Yang SK. Long-term prognosis of ulcerative colitis and its temporal changes between 1986 and 2015 in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea. Gut 2020;69:1432-40. [PMID: 31822581 DOI: 10.1136/gutjnl-2019-319699] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
28 Snell A, Segal J, Limdi J, Banerjee R. Inflammatory bowel disease in India: challenges and opportunities. Frontline Gastroenterol 2021;12:390-6. [DOI: 10.1136/flgastro-2020-101500] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
29 Ashktorab H, Brim H, Hassan S, Nouraie M, Gebreselassie A, Laiyemo AO, Kibreab A, Aduli F, Latella G, Brant SR, Sherif Z, Habtezion A. Inflammatory polyps occur more frequently in inflammatory bowel disease than other colitis patients. BMC Gastroenterol 2020;20:170. [PMID: 32503428 DOI: 10.1186/s12876-020-01279-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
30 Barnes EL, Bauer CM, Sandler RS, Kappelman MD, Long MD. Black and White Patients With Inflammatory Bowel Disease Show Similar Biologic Use Patterns With Medicaid Insurance. Inflamm Bowel Dis 2021;27:364-70. [PMID: 32405642 DOI: 10.1093/ibd/izaa090] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Park SH, Kim YJ, Rhee KH, Kim YH, Hong SN, Kim KH, Seo SI, Cha JM, Park SY, Jeong SK, Lee JH, Park H, Kim JS, Im JP, Yoon H, Kim SH, Jang J, Kim JH, Suh SO, Kim YK, Ye BD, Yang SK; Songpa-Kangdong Inflammatory Bowel Disease [SK-IBD] Study Group. A 30-year Trend Analysis in the Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District of Seoul, Korea in 1986-2015. J Crohns Colitis. 2019;13:1410-1417. [PMID: 30989166 DOI: 10.1093/ecco-jcc/jjz081] [Cited by in Crossref: 39] [Cited by in F6Publishing: 50] [Article Influence: 19.5] [Reference Citation Analysis]
32 Jangi S, Ruan A, Korzenik J, de Silva P. South Asian Patients With Inflammatory Bowel Disease in the United States Demonstrate More Fistulizing and Perianal Crohn Phenotype. Inflammatory Bowel Diseases 2020;26:1933-42. [DOI: 10.1093/ibd/izaa029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
33 Kang B, Kim JE, Jung JH, Choe JY, Kim MJ, Choe YH, Kim S, Koh H, Lee YM, Lee JH, Lee Y, Lee JH, Lee HJ, Jang HJ, Choi Y, Choi SY, Kim JY, Choe BH. Korean Children and Adolescents with Crohn's Disease Are More Likely to Present with Perianal Fistulizing Disease at Diagnosis Compared to Their European Counterparts. Pediatr Gastroenterol Hepatol Nutr 2020;23:49-62. [PMID: 31988875 DOI: 10.5223/pghn.2020.23.1.49] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
34 Huang JG, Aw MM. Pediatric Inflammatory Bowel Disease in Asia: Epidemiology and natural history. Pediatr Neonatol 2020;61:263-71. [PMID: 32005607 DOI: 10.1016/j.pedneo.2019.12.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
35 Mak WY, Zhao M, Ng SC, Burisch J. The epidemiology of inflammatory bowel disease: East meets west. J Gastroenterol Hepatol. 2020;35:380-389. [PMID: 31596960 DOI: 10.1111/jgh.14872] [Cited by in Crossref: 44] [Cited by in F6Publishing: 96] [Article Influence: 14.7] [Reference Citation Analysis]
36 Lee JL. Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease. Ann Coloproctol 2019;35:225-6. [PMID: 31725995 DOI: 10.3393/ac.2019.10.11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
37 Barnes EL, Kochar B, Long MD, Pekow J, Ananthakrishnan A, Anyane-Yeboa A, Martin C, Galanko J, Herfarth HH, Kappelman MD, Sandler RS. Lack of Difference in Treatment Patterns and Clinical Outcomes Between Black and White Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2018;24:2634-40. [PMID: 29788063 DOI: 10.1093/ibd/izy179] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
38 Song EM, Lee HS, Kim YJ, Oh EH, Ham NS, Kim J, Hwang SW, Park SH, Yang DH, Ye BD, Byeon JS, Myung SJ, Lee JL, Yoon YS, Yu CS, Yang SK. Incidence and Outcomes of Perianal Disease in an Asian Population with Crohn's Disease: A Nationwide Population-Based Study. Dig Dis Sci 2020;65:1189-96. [PMID: 31485994 DOI: 10.1007/s10620-019-05819-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
39 Seow CH, Targownik LE. Editorial: understanding sex and gender dimorphism in chronic diseases may improve outcomes. Aliment Pharmacol Ther 2019;50:603-4. [PMID: 31414536 DOI: 10.1111/apt.15421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Tepler A, Narula N, Peek RM Jr, Patel A, Edelson C, Colombel JF, Shah SC. Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease. Aliment Pharmacol Ther 2019;50:121-31. [PMID: 31165513 DOI: 10.1111/apt.15306] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
41 Galoosian A, Rezapour M, Liu B, Bhuket T, Wong RJ. Race/Ethnicity-specific Disparities in In-Hospital Mortality and Hospital Charges Among Inflammatory Bowel Disease-related Hospitalizations in the United States. Journal of Clinical Gastroenterology 2020;54:e63-72. [DOI: 10.1097/mcg.0000000000001204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
42 Shah SC, Khalili H, Chen CY, Ahn HS, Ng SC, Burisch J, Colombel JF. Sex-based differences in the incidence of inflammatory bowel diseases-pooled analysis of population-based studies from the Asia-Pacific region. Aliment Pharmacol Ther. 2019;49:904-911. [PMID: 30773656 DOI: 10.1111/apt.15178] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
43 Lee CK, Lee KM, Park DI, Jung SA, Jeen YT, Park YS, Kim HJ; MOSAIK study group of the Korean Association for the Study of Intestinal Diseases (KASID). A new opportunity for innovative inflammatory bowel disease research: the moderate-to-severe ulcerative colitis in Korea (MOSAIK) cohort study. Intest Res 2019;17:1-5. [PMID: 30678443 DOI: 10.5217/ir.2019.00005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
44 Agrawal M, Cohen-mekelburg S, Kayal M, Axelrad J, Galati J, Tricomi B, Kamal K, Faye AS, Abrudescu P, Scherl E, Lawlor G, Sultan K, Lukin D, Colombel J, Ungaro RC. Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio-economic factors. Aliment Pharmacol Ther 2019;49:564-71. [DOI: 10.1111/apt.15107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
45 Cabré E, Mañosa M, Marín I, Martín-Mateos R, Iglesias-Flores E, Barreiro-de-Acosta M, Nos P, Busquets D, Menchén LA, López-Sanromán A, Domènech E. Characteristics of inflammatory bowel disease in patients of Roma/Gypsy ethnicity. A case-control study. Dig Liver Dis 2019;51:669-74. [PMID: 30606697 DOI: 10.1016/j.dld.2018.12.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Parkman HP, Yamada G, Van Natta ML, Yates K, Hasler WL, Sarosiek I, Grover M, Schey R, Abell TL, Koch KL, Kuo B, Clarke J, Farrugia G, Nguyen L, Snape WJ, Miriel L, Tonascia J, Hamilton F, Pasricha PJ, McCallum RW. Ethnic, Racial, and Sex Differences in Etiology, Symptoms, Treatment, and Symptom Outcomes of Patients With Gastroparesis. Clin Gastroenterol Hepatol 2019;17:1489-1499.e8. [PMID: 30404035 DOI: 10.1016/j.cgh.2018.10.050] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
47 Shi HY, Ng SC. The state of the art on treatment of Crohn's disease. J Gastroenterol. 2018;53:989-998. [PMID: 29980848 DOI: 10.1007/s00535-018-1479-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
48 Fung BM, Perrault J, Tabibian JH. Ethnoracial, Geographic, and Socioeconomic Disparities and Variations in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2018;16:1176-7. [PMID: 29535055 DOI: 10.1016/j.cgh.2018.03.001] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Ananthakrishnan AN, Ng SC. Reply. Clin Gastroenterol Hepatol 2018;16:1177. [PMID: 29914642 DOI: 10.1016/j.cgh.2018.03.015] [Reference Citation Analysis]
50 Kochar B, Barnes EL, Herfarth HH, Martin CF, Ananthakrishnan AN, McGovern D, Long M, Sandler RS. Asians have more perianal Crohn disease and ocular manifestations compared with white Americans. Inflamm Intest Dis 2018;2:147-53. [PMID: 29876356 DOI: 10.1159/000484347] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]